Comparison

Thalidomide-O-amido-PEG2-C2-NH2 (hydrochloride) European Partner

Item no. HY-112617B-25mg
Manufacturer MedChem Express
CASRN 2376990-30-4
Amount 25 mg
Quantity options 100 mg 1 ea 25 mg 50 mg
Category
Type Inhibitors
Specific against other
Purity 98.0
Formula C21H27ClN4O8
Citations [1]ARYL SULFONOHYDRAZIDES. WO 2017/176958 A1.
Smiles O=C(NCCOCCOCCN)COC1=CC=CC(C(N2C(CC3)C(NC3=O)=O)=O)=C1C2=O.[H]Cl
ECLASS 10.1 32160490
ECLASS 11.0 32160490
UNSPSC 12000000
Shipping condition Room temperature
Available
Manufacturer - Type
Reference compound
Manufacturer - Applications
Cancer-programmed cell death
Manufacturer - Targets
Apoptosis; Autophagy; E3 Ligase Ligand-Linker Conjugates
Shipping Temperature
Room Temperature
Storage Conditions
-20°C, 3 years; 4°C, 2 years (Powder)
Molecular Weight
498.91
Product Description
Thalidomide-O-amido-PEG2-C2-NH2 hydrochloride incorporates an E3 ligase ligand and a linker, can be an immunomodulater for the treatment of cancer[1].
Manufacturer - Research Area
Cancer
Solubility
10 mM in DMSO
Manufacturer - Pathway
Apoptosis; Autophagy; PROTAC
Isoform
Cereblon
Clinical information
No Development Reported

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.

Amount: 25 mg
Available: In stock
available

Compare

Add to wishlist

Get an offer

Request delivery time

Ask a technical question

Submit a bulk request

Questions about this Product?
 
Close